MetaADEDB 2.0 @ LMMD
pimobendan
(GLBJJMFZWDBELO-UHFFFAOYSA-N)
Structure
SMILES
COc1ccc(cc1)c1nc2c([nH]1)cc(cc2)C1=NNC(=O)CC1C
Type(s)
Vet_approved
Molecular Formula:
C19H18N4O2
Molecular Weight:
334.372
Log P:
2.8630
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
79.37
CAS Number(s):
74150-27-9; 118428-36-7; 118428-37-8; 118428-38-9
Synonym(s)
1.
pimobendan
2.
4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinone
3.
UD CG 115
4.
UD-CG 115
5.
UD-CG115
6.
pimobendane
External Link(s)
MeSHC041648
PubChem Compound4823
BindingDB50282617
ChEBI32003
CHEMBLCHEMBL24646
DrugBankDB11450
DrugCentral2171
KEGGdr:D01133
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute respiratory failureOFFSIDES
2Altered state of consciousnessOFFSIDES
3AnorexiaOFFSIDES
4ApathyOFFSIDES
5AsphyxiaOFFSIDES
6AsthmaOFFSIDES
7Blood alkaline phosphatase increasedOFFSIDES
8Blood creatine phosphokinase increasedOFFSIDES
9Blood creatinine increasedOFFSIDES
10Blood glucose decreasedOFFSIDES
11Blood lactate dehydrogenase increasedOFFSIDES
12Blood urea increasedOFFSIDES
13Blood uric acidOFFSIDES
14Brain natriuretic peptide increasedOFFSIDES
15Cardiomegaly17556660CTD
16Cardiomyopathy, Dilated17556660
20428258
CTD
17CardiotoxicityOFFSIDES
18Cardiovirus Infections10193745CTD
19Catheter related infectionOFFSIDES
20Cold sweatOFFSIDES
21Congenital tricuspid valve incompetenceOFFSIDES
22Cortical laminar necrosisOFFSIDES
23DemyelinationOFFSIDES
24DizzinessOFFSIDES
25DyslaliaOFFSIDES
26Ejection Fraction DecreasedOFFSIDES
27EmbolismOFFSIDES
28Eosinophilic myocarditisOFFSIDES
29ErythropeniaOFFSIDES
30Escherichia infectionOFFSIDES
31Esophageal StenosisOFFSIDES
32Feeling abnormalOFFSIDES
33Gastric adenomaOFFSIDES
34Gastric mucosal lesionOFFSIDES
35Gastric ulcerOFFSIDES
36Gastrointestinal hypomotilityOFFSIDES
37Hepatic congestionOFFSIDES
38Hypertensive heart diseaseOFFSIDES
39HypoxiaOFFSIDES
40Implantable defibrillator insertionOFFSIDES
41Incorrect dose administeredOFFSIDES
42InfectionOFFSIDES
43Infusion site mobility decreasedOFFSIDES
44Leukopenia neonatalOFFSIDES
45Mechanical ventilationOFFSIDES
46MyeloblastomaOFFSIDES
47MyelodysplasiaOFFSIDES
48Myocarditis10193745CTD
49Nerve BlockOFFSIDES
50OrthopneaOFFSIDES
51PCO2 decreasedOFFSIDES
52PO2 decreasedOFFSIDES
53PericarditisOFFSIDES
54Physical examination abnormalOFFSIDES
55Pulmonary HypertensionOFFSIDES
56Pulmonary congestionOFFSIDES
57Renal cystOFFSIDES
58Sclerosing encapsulating peritonitisOFFSIDES
59Ventricular FibrillationOFFSIDES
60YawningOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.